Author:
Millan Mark J.,Iob Loretta,Péglion Jean-Louis,Dekeyne Anne
Publisher
Springer Science and Business Media LLC
Reference94 articles.
1. Arnt J (1988) The discriminative stimulus properties of the D1 agonist SK&F 38393 and the D2 agonist (−)-PNA are mediated by separate mechanisms. Life Sci 42:565–574
2. Assié MB, Ravailhe V, Faucillon V, Newman-Tancredi A (2005) Contrasting contribution of 5-hydroxytryptamine1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain. J Pharmacol Exp Ther 315:265–272
3. Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Despostes I, Bervoets K, Dekeyne A, Millan MJ (1998) A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists, (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287:187–197
4. Baker LE, Prus AJ (2002) Reevaluation of PNU-99194A discriminative stimulus effects potentiation by both a D2 antagonist and a D3/D2 agonist. Pharmacol Biochem Behav 73:753–758
5. Baker LE, Hood CA, Heidema AM (1999) Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats. Behav Pharmacol 10:717–722
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献